GPS: Clínica Médica

Fernanda Mazza · Capítulo 66 de 96

Páginas do PDF

GPS: Clínica Médica

Bibliografia Sugerida

Adrogué HJ, Madias NE. Hypernatremia. N Engl J Med. 2000; 342:1493-99.

Adrogué HJ, Madias NE. Hyponatremia. N Engl J Med. 2000; 342:1581-89.

Bagshaw SM, Langenberg C, Bellomo R. Urinary biochemistry and microscopy in septic acute renal failure: a systematic review. Am J

Kidney Dis 2006; 48:695-705

Berbece AN, Richardson RM. Sustained low-efficiency dialysis in the ICU: cost, anticoagulation, and solute removal. Kidney Int. 2006;

70(5):963-8.

Berl T, Quittnat-Pelletier F, Verbalis JG, Schier RW, Bichet DG, Ouyang J et al. Oral tolvaptan is safe and effective in chronic hyponatremia. J

Am Soc Nephrol. 2010; 21:705-12.

Brenner BM. Brenner e Rector’s. The kidney. 6. ed. Philadelphia: WB Saunders, 2000.

Burdmann EA, Oliveira MB, Ferraboli R et al: Epidemiologia. In: Schor N, Boim MA, dos Santos OFP (Eds.). Insu ciência Renal Aguda:

siopatologia, clínica e tratamento, São Paulo: Sarvier, 1997. p. 1.

Chertow GM et al. Acute Kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005; 16:3365-70.

Cockroft DW, Gault MH. Predicition of creatinine clearance from serum creatinine. Nephron. 1976; 16:31-41.

Costa MC, Yu L. Insu ciência renal aguda. Ars Curandi. 1997; 30(2):115-21.

Cuvello Neto AL, Yu L. Anticoagulação na terapia renal substitutiva contínua. In: Atualidades em Nefrologia 6. Cruz J, Barros RT, Cruz HMM

(Eds.). São Paulo: Sarvier, 2004. p. 204-13.

Ellison DH, Berl T. The syndrome of inappropriate antidiuresis. N Engl J Med. 2007; 356:2064-72.

Floege J, Johnson RJ, Feehally J. Comprehensive clinical nephrology. 4. ed. Philadelphia: Elsevier, 2010. p. 100-29.

Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med. 2002:113(IA);5S-13S.

Gross PA, Patel B. Reducing antibiotic overuse: a cal l for a national performance measure for not treating asymptomatic bacteriuria. Clin

Infect Dis. 2007; 45:1335-41.

Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary

tract infections. Ann Inter Med. 2001; 135:41-50.

Himmelfarb J. Continuous dialysis is not superior to intermittent dialysis in acute kidney injury of the critically ill patient. Nat Clin Pract

Nephrol. 2007; 3:120-21.

Hooton TM. Acute uncomplicated cystitis, pyelonephritis, and asymptomatic bacteriuria in men. Rev UpToDate. 2013. Disponível em:

httt://uptodate.com.

Hooton TM, Gupta K. Urinary tract infections and asymptomatic bacteriuria in pregnancy. Rev UpToDate. 2013. Disponível em:

httt://uptodate.com.

Katchman EA et al. Three-day vs longer duration of antibiotic treatment for cystitis in women: systematic review and metaanalysis. Am J

Med. 2005; 118(11):1196-207.

Kellum JA, Bellomo R, Ronco C. Classi cation of acute kidney injury using RIFLE: what’s the purpose? Crit Care Med. 2007; 35:1983-4.

Kielstein JT et al. Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: a randomized controlled study. Am J

Kidney Dis. 2004; 43(2):342-9.

Konstam MA, Gheorghiade M, Burnett JC, Grinfeld L, Maggioni AP, Swedberg K. Effects of oral tolvaptan in patients hospitalized for

worsening heart failure. JAMA. 2007; 297:1319-31.

Lameire N et al. Acute renal failure. Lancet. 2005; 365:417-30.

Langenberg C, Wan L, Egi M, May CN, Bellomo R. Renal blood ow in experimental septic acute renal failure. Kidney Int. 2006; 69:1996-

2002.

Levey AS et al. A more accurate method to estimate glomerular ltration rate from serum creatinine: a new prediction equation:

Modi cation of diet in renal disease study group. Ann Intern Med. 1999; 130:461-70.

Levey AS et al. National Kidney Foundation Practice Guidelines for chronic kidney disease: evaluation, classi cation and strati cation. Ann

Intern Med. 2003; 137-9.

Levey AS. Nondiabetic kidney disease. N Engl J Med. 2002; 347:1505.

Liangos O et al. Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey. Clin J Am Soc Nephrol. 2005;

1:43-51.

Liano F, Felipe C, Tenorio MT, Rivera M, Abraira V et al. Long-term outcome of acute tubular necrosis: a contribution to its natural history.

Kidney Int. 2007; 71:679-86.

Liaño F, Pascual J, The Madri Acute Renal Failure Study Group. Epidemiology of acute renal failure: a prospective, multicenter, community-

based study. Kidney Int. 1996; 50:811.

Lima EQ et al. Mortality risk factors and validation of severity scoring systems in critically ill patients with acute renal failure. Ren Fail.

2005; 27(5):547-56.

Longo DL, Kasper DL, Jameson JL, Fauci AS, Hauser SL, Loscalzo J. Harrison’s principles of internal medicine. 18. ed. New York: McGraw-Hill,

2012. p. 341-59.

Mehta RL et al. Acute Kidney Injury Network (AKIN): report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;

11:R31-38.

Mehta RL ET al. Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int. 2004; 66:1613-21.

Menon V, Sarnak MJ. The epidemiology of chronic kidney disease stages 1 to 4 and cardiovascular disease: a high risk combination. Am J

Kidney Dis. 2005; 45:223.

Molitoris BA, Levin A, Warnock DG, Joannidis M, Mehta RI et al. Improving outcomes of acute kidney injury: report of an initiative. Nat Clin

Pract Nephrol. 2007; 3(8):439-42.

National Kidney Foundation (K/DOQI). Clinical Practice Guidelines for chronic kidney disease: evaluation, classi cation and strati cation.

Am J Kidney Dis. 2002; 39:S122.

Nicole LE. Asymptomatic bacteriuria: when to screen and when to treat. Infec Dis Clin North Am. 2003;17:267-394.

Nicole LE, Bradley S, Colgan R et al. Infections Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic

bacteriuria in adults. Clin Infect Dis. 2005;40:643.

Palevsky PM. Clinical Review: Timing and dose of continuous renal replacement therapy in acute kidney injury. Critical Care. 2007; 11:232-

7.

Paltiel O, Salakhov E, Ronen I, Berg D, Israeli A. Management of severe hypokalemia in hospitalized patients. Arch Intern Med. 2001;

161:1089-95.

Petrov DB. An electrocardiographic sine wave in hyperkalemia. N Engl J Med. 2012; 366(19):1824.

Remuzzi G et al. Nephropaty in patients with type 2 diabetes. N Engl J Med. 2002; 346:1145.

Rocha PN. Hipercalemia. J Bras Nefrol. 2009; 31(1):5.

Rocha PN. Hiponatremia: conceitos básicos e abordagem prática. J Bras Nefrol. 2011; 33(2):248-260.

Ronco C et al. Effects of different doses in continuous veno-venous hemo ltration on outcomes of acute renal failure: a prospective

randomized trial. Lancet. 2000; 356:26-30.

Ronco C. Continuous dialysis is superior to intermittent dialysis in acute kidney injury of the critically ill patient. Nat Clin Pract Nephrol.

2007; 3:118-19.

Santos WJ et al. Patients with ischaemic, mixed and nephrotoxic acute tubular necrosis in the intensive care unit-a homogeneous

population? Crit Care. 2006;10(2):R68.

Saudan P et al. Adding a dialysis dose to continuous hemo ltration increases survival in patients with acute renal failure. Kidney Int. 2006;

70:1312-7.

Schier RW, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerwiec FS et al. Tolvaptan, a selective oral vasopressin v2-receptor antagonist, for

hyponatremia. N Engl J Med. 2006; 355:2099-112.

Schiffl H et al. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 2002; 346:305-10.

St Peter WL et al. Chronic Kidney disease: issues and establishing programs and clinics for improved patient outcomes. Am J Kidney Dis.

2003; 41:903.

Swaminathan S, Shah S. New insights into nephrogenic systemic brosis. J Am Soc Nephrol. 2007; 18(10):2636-43.

Uchino S et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005; 294:813-8.

Unwin RJ, Luft FC, Shirley DG. Pathophysiology and management of hypokalemia: a clinical perspective. Nat Rev Nephrol. 2011; 7:75-84.

Vinsonneau C et al. Continuous venovenous hemodia ltration versus intermittent hemodialysis for acute renal failure in patients with

multiple-organ dysfunction syndrome: a multicenter randomized trial. Lancet. 2006; 368:379-85.

Weisberg LS. Managemente of severe hyperkalemia. Crit Care Med. 2008; 36(12):1-6.

Yu L, Galvão PCA e Burdmann EA. Métodos Dialíticos em UTI. Ars Curandi. 1997; 30(4):44-53.

OceanofPDF.com